RecruitingNot ApplicableNCT06725823

Therapeutic Effect of Shoulder Anterior Capsular Block Versus Suprascapular Nerve Block in Patients With Frozen Shoulder

Therapeutic Effect of Shoulder Anterior Capsular Block (SHAC) Versus Suprascapular Nerve Block in Patients With Frozen Shoulder


Sponsor

Sohag University

Enrollment

50 participants

Start Date

Jan 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

he study will include 50 patients with frozen shoulder with no healthy volunteer , Patients in this study will be randomized into two groups suprascapular nerve block and Shoulder anterior capsular block


Eligibility

Min Age: 19 YearsMax Age: 65 Years

Inclusion Criteria4

  • Age above 18 years.
  • Both sexes, males and females.
  • History of complaint \>6 weeks
  • Restricted shoulder movement unilaterally in at least 2 planes including abduction, external rotation, and internal rotation and restricted passive movement.

Exclusion Criteria9

  • Patient refusal.
  • Allergy to local anaesthetics.
  • Infection at the site of injection .
  • Coagulopathy
  • Prolonged opioid medication
  • Pregnancy
  • Acute trauma, fracture of the shoulder
  • People who had received an intra-articular shoulder injection within the last 6 months.
  • Patients with tendon tear

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREsuprascapular nerve block group

A volume of (10 ml) of 2% lidocaine (7ml), 3% Mepivacaine (2ml), 1 ml methyl-prednisolone acetate (40 mg) will be injected to both groups.

PROCEDUREshoulder anterior capsular block group

A volume of (10ml) of 2% lidocaine (7ml), 3% Mepivacaine (2ml), 1 ml methyl-prednisolone acetate (40mg) will be injected to both groups.


Locations(1)

Sohag university

Sohag, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06725823


Related Trials